Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia-Reference-Cited by-同舟云学术

Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia

Published:2017-03 Issue: Volume:86 Page:9-17
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Eisenstein Sarah A.,Bogdan Ryan,Chen Ling,Moerlein Stephen M.,Black Kevin J.,Perlmutter Joel S.,Hershey Tamara,Barch Deanna M.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference92 articles.

1. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response–a double-blind PET study in schizophrenia;Agid;Neuropsychopharmacology,2007

2. The Scale for the Assessment of Negative Symptoms (SANS);Andreasen,1983

3. Scale for the Assessment of Positive Symptoms (SAPS);Andreasen,1983

4. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans;Antenor-Dorsey;Nucl. Med. Biol.,2008

5. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants;Asghari;J. Neurochem.,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Apathy and Motivation: Biological Basis and Drug Treatment;Annual Review of Pharmacology and Toxicology;2024-01-23

3. Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings;Progress in Neurobiology;2022-06

4. The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia;Current Issues in Molecular Biology;2021-07-08

5. Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol;Frontiers in Psychiatry;2020-11-05